AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Ascendis Pharma A/S
$251.27
+$37.98 (+17.81%)
Previous Close
$253.00
Day Range
$249.55$255.61
Year Range
$188.07$282.15
Market Cap
16.53B
AVG Volume
724.75K
Trailing/Forward PE
18.57/27.6
PEG ratio
-0.03
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
NASDAQ
EBITDA · Q
Cash Flows · Q
EPS · Q
Expenses · Q
Cash & Debt · Q
Debt ratios · Q
Margins · Q
Return on Capital · Q
Shares Outstanding · Q
Dividends (EUR) · Q
Employee Count
Book Value Per Share · Q
Total Assets · Q
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Earnings: ASND
Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 11 Nov 2026.
Video analysis: ASND
All videosNo video analysis for this stock yet. Request one from our team.
News: ASND
Similar companies
-
Xeris Biopharma Holdings, Inc.
XERS
·
NASDAQ
Compare
-
Septerna Inc
SEPN
·
NASDAQ
Compare
-
MBX Biosciences, Inc. Common Stock
MBX
·
NASDAQ
Compare
-
BioMarin Pharmaceutical Inc.
BMRN
·
NASDAQ
Compare
-
Ultragenyx Pharmaceutical Inc.
RARE
·
NASDAQ
Compare
-
Corcept Therapeutics Incorporated
CORT
·
NASDAQ
Compare